On February 25, 2021 ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, reported that Dr. David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at three upcoming virtual investor conferences (Press release, ESSA, FEB 25, 2021, View Source [SID1234575706]). Peter Virsik, ESSA’s Chief Operating Officer, and David S. Wood, ESSA’s Chief Financial Officer, will also be available for one-on-one meetings.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Event: Cowen 41st Annual Health Care Conference
Date: Thursday, March 4, 2021
Time: 12:10 p.m. ET

Event: H.C. Wainwright Annual Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time (on-demand): 7:00 a.m. ET

Event: Oppenheimer 31st Annual Healthcare Conference
Date: Thursday, March 18, 2021
Time: 11:20 a.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA’s website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.